BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3094463)

  • 1. A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritis.
    Capell HA; Lewis D; Carey J
    Ann Rheum Dis; 1986 Sep; 45(9):705-11. PubMed ID: 3094463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between sodium aurothiomalate and auranofin in rheumatoid arthritis. Results of a two-year open randomized study.
    Harth M; Davis P; Thompson JM; Menard H; Beaudet F
    Scand J Rheumatol; 1987; 16(3):177-84. PubMed ID: 3110944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auranofin and gold sodium thiomalate in the treatment of rheumatoid arthritis: a one-year, double-blind, comparative multicenter study.
    Schattenkirchner M; Bröll H; Kaik B; Müller-Fassbender H; Rau R; Zeidler H
    Klin Wochenschr; 1988 Feb; 66(4):167-74. PubMed ID: 3131571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Subsets of responses.
    Ward JR; Williams HJ; Boyce E; Egger MJ; Reading JC; Samuelson CO
    Am J Med; 1983 Dec; 75(6A):133-7. PubMed ID: 6419595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A three year comparative study of auranofin and gold sodium thiomalate in rheumatoid arthritis.
    Rau R; Schattenkirchner M; Muller-Fassbender H; Kaik B; Zeidler H; Missler B
    Clin Rheumatol; 1990 Dec; 9(4):461-74. PubMed ID: 2128475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis.
    Jessop JD; O'Sullivan MM; Lewis PA; Williams LA; Camilleri JP; Plant MJ; Coles EC
    Br J Rheumatol; 1998 Sep; 37(9):992-1002. PubMed ID: 9783766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte membrane gold levels after treatment with auranofin and sodium aurothiomalate.
    Iqbal MS; Saeed M; Taqi SG
    Biol Trace Elem Res; 2008; 126(1-3):56-64. PubMed ID: 18649049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
    Leonard PA; Bienz SR; Clegg DO; Ward JR
    J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
    Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
    J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Well controlled comparative study in early rheumatoid arthritis with gold sodium thiomalate vs. auranofin].
    Yamamoto S; Mitomo N; Saito T; Nishioka K; Inoue K; Uchida S; Ohata N; Murasawa A; Suzuki A; Mitsui T
    Ryumachi; 1990 Feb; 30(1):26-44. PubMed ID: 2116042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A three year comparative multicenter study of auranofin (AF) and gold sodium thiomalate (GST) in the treatment of rheumatoid arthritis (RA).
    Rau R; Schattenkirchner M; Müller-Fassbender H; Kaik B; Zeidler H
    Clin Rheumatol; 1987 Sep; 6 Suppl 2():43-52. PubMed ID: 3121238
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral gold: a comparison with placebo and with intramuscular sodium aurothiomalate.
    Lewis D; Capell HA
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():83-96. PubMed ID: 6432418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of the effects of auranofin and aurothiomalate on laboratory and clinical indicators in patients with rheumatoid arthritis].
    Vlak T; Stambuk B
    Reumatizam; 1998; 46(1):7-19. PubMed ID: 9921004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-year experience in patients treated with auranofin following completion of a parallel, controlled trial comparing auranofin, gold sodium thiomalate, and placebo.
    Williams HJ; Dahl SL; Ward JR; Karg M; Willkens RF; Meenan RF; Altz-Smith M; Clegg DO; Mikkelsen WM; Kay DR
    Arthritis Rheum; 1988 Jan; 31(1):9-14. PubMed ID: 3125841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin.
    Menard HA; Beaudet F; Davis P; Harth M; Percy JS; Russell AS; Thompson JM
    J Rheumatol Suppl; 1982; 8():179-83. PubMed ID: 6813482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gold levels produced by treatment with auranofin and sodium aurothiomalate.
    Lewis D; Capell HA; McNeil CJ; Iqbal MS; Brown DH; Smith WE
    Ann Rheum Dis; 1983 Oct; 42(5):566-70. PubMed ID: 6414387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
    Batlle Gualda E
    Med Clin (Barc); 1985 Jun; 85(2):73-9. PubMed ID: 3160899
    [No Abstract]   [Full Text] [Related]  

  • 19. Early and late changes in sulphydryl group and copper protein concentrations and activities during drug treatment with aurothiomalate and auranofin.
    Rae KJ; Mackay CN; McNeil CJ; Brown DH; Smith WE; Lewis D; Capell HA
    Ann Rheum Dis; 1986 Oct; 45(10):839-46. PubMed ID: 3098194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of oral and parenteral gold therapy--review of the literature].
    Thumb N
    Wien Klin Wochenschr Suppl; 1984; 156():44-8. PubMed ID: 6442057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.